Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: A randomized controlled trial

Anma therapy (Japanese massage therapy, AMT) significantly reduces the severity of physical complaints in survivors of gynecologic cancer. However, whether this reduction of severity is accompanied by improvement in health-related quality of life is unknown. Forty survivors of gynecologic cancer wer...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-05, Vol.13 (5), p.e0196638-e0196638
Main Authors: Donoyama, Nozomi, Satoh, Toyomi, Hamano, Tetsutaro, Ohkoshi, Norio, Onuki, Mamiko
Format: Article
Language:English
Subjects:
Analysis
Anxiety
Biology and Life Sciences
Breast cancer
Cancer
Cancer survivors
Clinical trials
Cognition & reasoning
Fatigue
Global health
Gynecology
Health aspects
Health sciences
Insomnia
Massage
Medicine and Health Sciences
Mental depression
Mood
Obstetrics
Ovarian cancer
Pain
Patients
Quality of life
Reflexology
Shiatsu
Sleep disorders
Social Sciences
Supervision
Systematic review
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anma therapy (Japanese massage therapy, AMT) significantly reduces the severity of physical complaints in survivors of gynecologic cancer. However, whether this reduction of severity is accompanied by improvement in health-related quality of life is unknown. Forty survivors of gynecologic cancer were randomly allocated to either an AMT group that received one 40-min AMT session per week for 8 weeks or a no-AMT group. We prospectively measured quality of life by using the Japanese version of the European Organization for Research and Treatment of Cancer QLQ-C30 version 3.0 (EORTC QLQ-C30) at baseline and at 8-week follow-up. The QLQ-C30 response rate was 100%. Hospital Anxiety Depression Scale (HADS), Profile of Mood States (POMS), and Measure of Adjustment to Cancer were also prespecified and prospectively evaluated. The QLQ-C30 Global Health Status and Quality of Life showed significant improvement at 8 weeks (P = 0.042) in the AMT group compared with the no-AMT group, and the estimated mean difference reached a minimal clinically important difference of 10 points (10.4 points, 95% CI = 1.2 to 19.6). Scores on fatigue and insomnia showed significant improvement in the AMT group compared with the no-AMT group (P = 0.047 and 0.003, respectively). There were no significant between-group improvements in HADS anxiety and depression scales; however, POMS-assessed anger-hostility showed significant improvement in the AMT group compared with the no-AMT group (p = 0.028). AMT improved health-related quality of life in gynecologic cancer survivors. AMT can be of potential benefit for applications in oncology.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0196638